Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
175 NOK | +0.57% | -0.57% | -18.22% |
Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Apr. 02 | Medistim ASA Proposes Dividend | CI |
Sales 2024 * | 539M 49.2M | Sales 2025 * | 563M 51.39M | Capitalization | 3.19B 291M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 5.77 x |
Net cash position 2024 * | 78M 7.12M | Net cash position 2025 * | 119M 10.86M | EV / Sales 2025 * | 5.45 x |
P/E ratio 2024 * |
29.6
x | P/E ratio 2025 * |
26.9
x | Employees | 151 |
Yield 2024 * |
2.59% | Yield 2025 * |
1.94% | Free-Float | 74.3% |
Latest transcript on Medistim ASA
1 week | -3.87% | ||
Current month | -6.45% | ||
1 month | -2.52% | ||
3 months | -16.75% | ||
6 months | -6.45% | ||
Current year | -18.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09-08-31 | |
Director of Finance/CFO | - | 00-12-31 | |
Anne Waaler
CTO | Chief Tech/Sci/R&D Officer | 68 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 99-12-31 | |
Director/Board Member | 54 | 23-03-31 | |
Lars Rønn
BRD | Director/Board Member | 60 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 175 | +0.57% | 2 701 |
24-04-25 | 174 | -6.70% | 29,751 |
24-04-24 | 186.5 | +5.07% | 4,654 |
24-04-23 | 177.5 | +0.85% | 4,082 |
24-04-22 | 176 | 0.00% | 7,063 |
Real-time Oslo Bors, April 25, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.69% | 290M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.57% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- MEDI Stock